TCR Publications | Juno Therapeutics

TCR Publications

Review Articles Covering T Cell Receptors and Clinical Trials for B Cell Malignancies For additional information about T Cell Receptors and the results of early clinical trials in B cell malignancies, see the following review articles.

Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches. Front Oncol. 2017;7:64.

Kamta J, Chaar M, Ande A, et al.

Engineering chimeric human and mouse major histocompatibility complex (MHC) class I tetramers for the production of T-cell receptor (TCR) mimic antibodies. PLoS One. 2017;12(4):e0176642.

Li D, Bentley C, Yates J, Salimi M, et al.

Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6(3):e1283460.

Van Caeneghem Y, De Munter S, Tieppo P, et al.

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification. Mol Ther Methods Clin Dev. 2017 Feb 12;4:213-224.

Knipping F, Osborn MJ, Petri K, et al.

Dynamical footprint of cross-reactivity in a human autoimmune T-cell receptor. Sci Rep. 2017;7:42496.

Kumar A, Delogu F.

DynaDom: structure-based prediction of T cell receptor inter-domain and T cell receptor-peptide-MHC (class I) association angles.

Hoffmann T, Marion A, Antes I.

TCR signaling by conventional CD4+ T cells is required for optimal maintenance of peripheral regulatory T cell numbers. Immun Inflamm Dis. 2016;4(2):148-154.

Leichner TM, Satake A, Kambayashi T.

Understanding CD8+ T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope. Clin Transl Immunology. 2017 Mar 17;6(3):e134.

Nguyen TH, Tan AC, Xiang SD, et al.

Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases. Front Immunol. 2017 Mar 27;8:316.

Barbarin A, Cayssials E, Jacomet F, et al.